Intra-patient variability of tacrolimus levels and cardiac allograft outcomes
File(s) ISHLT Tac variability in OCTx 2015 poster FINAL.pdf (615.38 KB)
Published version
Author(s)
Type
Conference Paper
Abstract
Intra-patient variability (IPV) of tacrolimus (TAC) levels is a risk factor for poor long-term outcomes after renal transplantation. Immunosuppression was induction with rabbit anti-thymocyte globulin, TAC, mycophenolate mofetil and corticosteroids. Steroids were weaned over 6-12 months and TAC dose reduced. The aim of this study was to investigate whether high IPV of TAC levels within the first year after heart transplantation was associated with poor outcomes.
Date Issued
2016-04-30
Date Acceptance
2016-04-27
Citation
Journal of Heart and Lung Transplantation, 2016, 35 (4), pp.S418-S418
ISSN
1053-2498
Publisher
Elsevier
Start Page
S418
End Page
S418
Journal / Book Title
Journal of Heart and Lung Transplantation
Volume
35
Issue
4
Copyright Statement
© 2016 Published by Elsevier Inc.
Identifier
http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000374718101519&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=1ba7043ffcc86c417c072aa74d649202
Source
36th Annual Meeting and Scientific Sessions of the International-Society-for-Heart-and-Lung-Transplantation (ISHLT)
Subjects
Science & Technology
Life Sciences & Biomedicine
Cardiac & Cardiovascular Systems
Respiratory System
Surgery
Transplantation
Cardiovascular System & Cardiology
1102 Cardiovascular Medicine And Haematology
Publication Status
Published
Start Date
2016-04-27
Finish Date
2016-04-30
Coverage Spatial
Washington, DC
